Compare ARK Genomic Revolution ETF (ARKG) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $57.67. Which is the better fit depends on your goals.
| ARKG | SPUS | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $59.51 |
52-Week Low | $23.09 | $45.08 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SPUS, a US stock, trades at $57.78, up 0.56% today, with a bullish technical signal from moving averages and neutral oscillators. Recent corporate actions include quarterly dividends of $0.03, with the latest paid on June 26, 2026. Key financial ratios like P/E and P/S are unavailable in the provided data, limiting fundamental depth. Support and resistance levels cluster near the current price, indicating potential volatility.
The outlook for SPUS is cautiously optimistic, driven by technical strength and dividend consistency, but lacks clear fundamental metrics. Risks include market volatility and reliance on broader equity trends. Investment opportunity hinges on technical momentum, while the absence of valuation data warrants careful analysis for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
